What are the alternative treatment options for relapsed or elderly AML patients?
Novel therapeutic options for Waldenström’s macroglobulinemia
A future study linking tumor genetics with CLL dynamics
Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Gareth Morgan et al.
The Myeloma 2016 meeting: Integrating science and clinical practice